Platelet Aggregation Devices Market Industry Outlook Presents Revenue And CAGR Projections To 2030
How Has The Size And Value Of The Platelet Aggregation Devices Market Changed During The 2026–2030 Period?
The platelet aggregation devices market size has grown exponentially in recent years. It will grow from $1.04 billion in 2025 to $1.31 billion in 2026 at a compound annual growth rate (CAGR) of 25.4%. The growth in the historic period can be attributed to growth in cardiovascular disease prevalence, expansion of clinical diagnostic laboratories, increasing use of antiplatelet therapies, rising demand for coagulation testing, advancements in hematology diagnostics.
The platelet aggregation devices market size is expected to see exponential growth in the next few years. It will grow to $2.94 billion in 2030 at a compound annual growth rate (CAGR) of 22.5%. The growth in the forecast period can be attributed to growing adoption of personalized medicine, increasing investments in advanced diagnostics, rising demand for rapid platelet function testing, expansion of research in blood disorders, continuous innovation in diagnostic technologies. Major trends in the forecast period include increasing adoption of automated platelet function analyzers, growing demand for high-throughput testing systems, rising integration of digital data management, expansion of multi-channel aggregation devices, enhanced focus on diagnostic accuracy.
Claim Your Free Report Sample Today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp
What Drivers Are Contributing To The Expansion Trajectory Of The Platelet Aggregation Devices Market?
The increasing incidence of target diseases is expected to drive the platelet aggregation devices market going forward. Target diseases are specific medical conditions that are the focus of prevention, diagnosis, and treatment efforts due to their significant impact on public health, such as cancer, cardiovascular diseases, and diabetes. Platelet aggregation devices help in decreasing the incidence of target diseases by enabling early detection and effective management of thrombotic risks, thereby preventing complications like heart attacks and strokes in vulnerable populations. For instance, in February 2024, according to statistics published by the International Agency for Research on Cancer (IARC), a France-based specialized cancer agency of the World Health Organization (WHO), the world saw approximately 20 million new cancer cases and 9.7 million deaths in 2022, with projections indicating a 77% increase to over 35 million new cases by 2050; lung cancer was the most prevalent globally with 2.5 million new cases (12.4%), followed by female breast cancer (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Therefore, the increasing incidence of target diseases is driving the growth of the platelet aggregation devices market.
Which Primary Segments Are Included In The Detailed Analysis Of The Platelet Aggregation Devices Market?
The platelet aggregation devices market covered in this report is segmented —
1) By Product: Reagents, Systems, Consumables And Accessories
2) By Channel Configuration: Four Channel, Dual Channel, Eight Channel
3) By Technology: Optical, Impedance, Other Technologies
4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Other Applications
5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users
Subsegments:
1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents
2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems
3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits
Which Trends Are Currently Influencing The Direction Of The Platelet Aggregation Devices Market?
Major companies operating in the platelet aggregation devices market are increasing their focus on developing advanced solutions by launching innovative products such as the first platelet pooling set to help stabilize the U.S. platelet supply and meet growing needs. A platelet pooling set is a specialized medical device used during plateletpheresis procedures to collect and concentrate platelets from multiple donors into a single unit for transfusion therapy. For instance, in February 2023, Terumo BCT Inc., a US-based company providing blood components and cellular technology, announced the approval of the IMUGARD WB Platelet Pooling Set by the Food and Drug Administration (FDA), a US-based federal agency. This offers extended shelf life for platelets, FDA clearance for seven-day storage, and enables platelet recoupment from whole blood donations, enhancing flexibility and availability in the platelet aggregation devices market. This launch represents a significant technological advancement by addressing the need for improved platelet availability, more efficient supply management, and supporting strained U.S. platelet supply to meet increasing demand in critical medical procedures like chemotherapy and organ transplants.
Which Major Corporations Play A Crucial Role In The Platelet Aggregation Devices Market Landscape?
Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG And Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago, Instrumentation Laboratory
Get Your In-Depth Platelet Aggregation Devices Market Report Now:
https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report
Which Regions Demonstrate The Highest Growth Momentum In The Platelet Aggregation Devices Market?
North America was the largest region in the platelet aggregation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310–496–7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment